Recombinant Proteins Market Size, Share, Latest Trend, Top Companies and Growth Forecast Report, 2030

The recombinant proteins market will grow at a double-digit compound annual growth rate in the years to come, to touch USD 3,203.7 million by 2030.

The growth of the industry has a lot to do with the growing collaboration between pharma sector and universities, the increasing occurrence of key genetic disorders and infectious diseases. Furthermore, the snowballing research on biological drugs and the growing investments of the government for this purpose will power the industry in the years to come.

Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/recombinant-proteins-market/report-sample

The growth factors and chemokines category had the largest share, and it will grow at a rate of about 12% in the years to come. This has a lot to do with the use of growth factors and chemokines in a number of research studies on cancer, COVID19, neurobiology, immunology, and HIV/AIDS.

Biologics dominated the recombinant proteins market, with a share of approximately 60%, in 2022, and they will grow at the highest rate in the future. This is due to the fact that the increasing predisposition of pharma and biopharma firms toward powering their biologics and biosimilars research and development efforts and product pipelines, formulating novel technologies, and progressing the bioprocessing science.

This is because of the increasing requirement for biopharma, their widening uses, and the increasing competition amongst the key players.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=recombinant-proteins-market

North America dominated the industry, with a share of about 45%, in 2022, as a result of the increasing incidence of chronic and infectious disorders and favorable initiatives of the government.

Moreover, the increasing requirement for this kind of products in the R&D studies being carried out by the key players is enhancing the industry.

The U.S. has a larger share as a result of the high expenditure on research facilities, innovations in treatment, and robust incidence of key players.

Apart from this, the U.S. is observing a growing occurrence of chronic illnesses, such as diabetes and cancer, which urges healthcare companies to pursue progressions in recombinant proteins.

Furthermore, the increasing acceptance of these agents in the nation is considerably influenced by its growing per capita healthcare outlay.

APAC will grow the fastest in the years to come. This can be credited to the wide-ranging growth in pharma contract development and industrial efforts in the recent past.

Browse full report at: https://www.psmarketresearch.com/market-analysis/recombinant-proteins-market

Furthermore, the increasing populace and its increasing requirement for an enhanced access to drugs; and the growing affordability of biopharmaceuticals, with the beginning of affordable generics are leading to the development of the regional industry.

It is because of the increasing prevalence of primary infectious disease and generic ailments all over the world, the requirement for recombinant proteins will continue to grow in the years to come.

Market Size Breakdown by Segment

By End User
• Pharmaceutical & Biopharmaceutical Companies
• Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
By Application
• Drug Discovery & Development
o Biologics
o Vaccines
o Cell & gene therapies
• Biopharmaceutical Production
• Biotechnology Research
• Academic Research Studies
• Diagnostics
By Product
• Growth Factors and Chemokines
• Immune Response Proteins
• Structural Proteins
• Membrane Proteins
• Kinase Proteins
• Regulatory Proteins
• Recombinant Metabolic Enzymes
• Adhesion Molecules and Receptors

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://www.psmarketresearch.com/blogs

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.